Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma co-led by Arix to create best-in-class engineered cell therapy platform London, UK, 5 January 2023 – Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company fo.
DJ Portfolio company Twelve Bio to be acquired alongside USD85 million financing of Ensoma Arix Bioscience PLC (ARIX) Portfolio company Twelve Bio to be acquired alongside USD85 million financing